WVE
Wave Life Sciences Ltd.Data as of 2026 Q2 (06-30) · 13F snapshot
Summary
Wave Life Sciences Ltd. (WVE) is held as common stock by 6 tracked hedge-fund managers, with a combined reported value of ~$37.63M; the largest are Izzy Englander, Renaissance Technologies, Steven Cohen. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 2 added, 1 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders62 also report options
Congress trades0
Price$3.64vs quarter-end-37.35%
Sectors0
This quarter's moves
Top holderNew1
Added2
Trimmed / sold2
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $4.78M0.0% of portfolio822,6382026 Q2
Value $1.00M0.0% of portfolio173,0002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $4.78M | 0.0% | Hold |
| Stanley Druckenmiller | $1.00M | 0.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $406.1K— of portfolio69,9002026 Q2
Value $399.1K— of portfolio68,7002026 Q2
Value $16.3K— of portfolio2,8002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $406.1K | — | — |
| Ken GriffinPUT | $399.1K | — | — |
| Steven CohenCALL | $16.3K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.